Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mercuri

Showing results (211-220 of 259) with videos related to

Pageof 26
Sort By:
Cancer|December 1, 1993
Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicinG Bacci, P Picci, S Ferrari, et al.
Cancer|June 1, 1990
Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatinG Bacci, P Picci, P Ruggieri, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2002
Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic InstituteG Bacci, M Mercuri, A Longhi, et al.
Journal of Chemotherapy (Florence, Italy)|January 6, 1999
Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremityS Ferrari, M Mercuri, P Rosito, et al.
La Radiologia Medica|March 23, 2011
Selective arterial embolisation for bone tumours: experience of 454 casesG Rossi, A F Mavrogenis, E Rimondi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Proteases and interleukin-6 gene analysis in 92 giant cell tumors of boneG Gamberi, M S Benassi, P Ragazzini, et al.
European Journal of Pediatrics|July 22, 2021
Neurological development and iron supplementation in healthy late-preterm neonates: a randomized double-blind controlled trialR Luciano, D M Romeo, G Mancini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatinG Bacci, S Ferrari, N Delepine, et al.
Acta Oncologica (Stockholm, Sweden)|May 8, 1998
Neoadjuvant chemotherapy for extremity osteosarcoma--preliminary results of the Rizzoli's 4th studyG Bacci, S Ferrari, M Mercuri, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|June 16, 2026
Iodine Nutrition in Emilia-Romagna Region, Italy: A Successful Story of Prevention of Iodine Deficiency DisordersD Meringolo, D Rotondi, D Bianchi, et al.
Pageof 26

Showing results (211-220 of 259) with videos related to

Sort By:
Pageof 26
Cancer|December 1, 1993
Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicinG Bacci, P Picci, S Ferrari, et al.
Cancer|June 1, 1990
Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatinG Bacci, P Picci, P Ruggieri, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2002
Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic InstituteG Bacci, M Mercuri, A Longhi, et al.
Journal of Chemotherapy (Florence, Italy)|January 6, 1999
Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremityS Ferrari, M Mercuri, P Rosito, et al.
La Radiologia Medica|March 23, 2011
Selective arterial embolisation for bone tumours: experience of 454 casesG Rossi, A F Mavrogenis, E Rimondi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Proteases and interleukin-6 gene analysis in 92 giant cell tumors of boneG Gamberi, M S Benassi, P Ragazzini, et al.
European Journal of Pediatrics|July 22, 2021
Neurological development and iron supplementation in healthy late-preterm neonates: a randomized double-blind controlled trialR Luciano, D M Romeo, G Mancini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatinG Bacci, S Ferrari, N Delepine, et al.
Acta Oncologica (Stockholm, Sweden)|May 8, 1998
Neoadjuvant chemotherapy for extremity osteosarcoma--preliminary results of the Rizzoli's 4th studyG Bacci, S Ferrari, M Mercuri, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|June 16, 2026
Iodine Nutrition in Emilia-Romagna Region, Italy: A Successful Story of Prevention of Iodine Deficiency DisordersD Meringolo, D Rotondi, D Bianchi, et al.
Pageof 26